Adage Capital Partners’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-870,000
| Closed | -$3.05M | – | 904 |
|
|
2024
Q3 | $3.05M | Hold |
870,000
| – | – | 0.01% | 756 |
|
|
2024
Q2 | $2.85M | Sell |
870,000
-1,270,000
| -59% | -$4.17M | 0.01% | 758 |
|
|
2024
Q1 | $15.7M | Buy |
2,140,000
+440,000
| +26% | +$3.23M | 0.03% | 512 |
|
|
2023
Q4 | $6.36M | Buy |
+1,700,000
| New | +$6.36M | 0.01% | 661 |
|
|
2020
Q4 | – | Sell |
-44,000
| Closed | -$1.76M | – | 838 |
|
|
2020
Q3 | $1.76M | Buy |
+44,000
| New | +$1.76M | ﹤0.01% | 708 |
|